General MedicationsORAL, RECTALStandard

SODIUM POLYSTYRENE SULFONATE

Standard Dose

453.6GM/BOT

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview SODIUM POLYSTYRENE SULFONATE is listed in Drugs@FDA under application 202333 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient SODIUM POLYSTYRENE SULFONATE Form and strength POWDER;ORAL, RECTAL - 453.6GM/BOT Sponsor EPIC PHARMA LLC Submission history Latest submission status date: 2020-02-25 00:00:00.

Structured Monograph

Clinical summary

Approval overview SODIUM POLYSTYRENE SULFONATE is listed in Drugs@FDA under application 202333 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient SODIUM POLYSTYRENE SULFONATE Form and strength POWDER;ORAL, RECTAL - 453.6GM/BOT Sponsor EPIC PHARMA LLC Submission history Latest submission status date: 2020-02-25 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.